A record of what Prashanth Tapse said publicly, with the source. Not advice.
“Recommends buying Dr. Reddy’s Labs for the short term, with a target of ₹1,250 / ₹1,265 and a stop-loss at ₹1,185. The stock maintains a positive bias near the ₹1,200 zone with sustained volume and a constructive trend, supported by consistent higher lows and healthy momentum.”
Prashanth Tapse’s track record (trackable calls only): 94 graded calls · 95% CI 21–40%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
No entry price is stated, so the call starts at the first close after it was published.
Target ₹1,250, stop ₹1,185, as stated.
Window: 30 days, from the call's own horizon word ("for the short term").
The target ₹1,250 was reached on a close before the stop ₹1,185. Hit.
The grader’s working: R4 TARGET_CALL: entered ₹1198.7 on 2025-11-10 (next trading session's close); target ₹1250 reached at close ₹1250.2 on 2025-11-19. Window 30 days — rule H4: the quote says "for the short term" (short-term 30 days, medium-term 90, long-term 12 months).
How it played out
How this is worked out- Target or stop first
- The target was reached on a close before the stop was.
- Time to target
- The target was reached on a close 7 trading sessions (9 calendar days) after the entry.
- Worst close against it
- No close was ever against the call before the target was reached. Closing prices only; an intraday dip is never counted.
From the entry the grade used, on closing prices. This is a record of one past call and is not advice.